LIF Antikörper (C-Term)
Kurzübersicht für LIF Antikörper (C-Term) (ABIN7185096)
Target
Alle LIF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- LIF Antibody
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human LIF.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Andere Bezeichnung
- LIF
-
Hintergrund
- CDF antibody, Cholinergic Differentiation Factor antibody, D factor antibody, DIA antibody, Differentiation inducing factor antibody, differentiation inhibitory activity antibody, Differentiation stimulating factor antibody, Differentiation-stimulating factor antibody, Emfilermin antibody, Hepatocyte stimulating factor III antibody, HILDA antibody, Human interleukin in DA cells antibody, Leukemia inhibitory factor antibody, LIF antibody, LIF_HUMAN antibody, Melanoma derived LPL inhibitor antibody, Melanoma-derived LPL inhibitor antibody, MLPLI antibody
-
UniProt
- P15018
-
Pathways
- JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Target
-